Xuyao Zhang

4 ta ish

Fudan University

1. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

   Caili Xu, Min Zhu, Qian Wang +11

   MaqolaOAOchiq kirish20235 iqtibos

   ABIABI:AkademIndex/2026.other.104173

2. Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer

   Wenjing Xue, Caili Xu, Kaiqi Zhang +6

   MaqolaOAOchiq kirish20245 iqtibos

   ABIABI:AkademIndex/2026.other.133452

3. Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer

   Caili Xu, Xiting Huang, Qinchao Hu +7

   MaqolaOAOchiq kirish20244 iqtibos

   ABIABI:AkademIndex/2026.other.133460

4. Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models

   Yanyang Nan, Min Zhu, Qian Wang +10

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.474316